Crossmark

Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC

Crossref DOI link: https://doi.org/10.1186/s12964-024-01782-9

Published Online: 2024-08-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pieper, Nadja M.

Schnell, Julia

Bruecher, Daniela

Knapp, Stefan

Vogler, Meike http://orcid.org/0000-0003-2650-586X
Funding

Funding for this research was provided by:

Johann Wolfgang Goethe-Universität, Frankfurt am Main
License Information

Text and Data Mining valid from 2024-08-27

Version of Record valid from 2024-08-27
More Information

Article History

Received: 25 April 2024

Accepted: 6 August 2024

First Online: 27 August 2024

Declarations

:

: This study did not require ethical approval.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below